XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Gain/(Loss), Net of Tax [Member]
Retained Earnings/(Accumulated Deficit) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings/(Accumulated Deficit) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance at Dec. 31, 2018 $ 1 $ 186,812 $ (659) $ (379) $ 2 $ 11,488 $ 2 $ 197,263
Balance (in shares) at Dec. 31, 2018 11,863   11          
Increase (decrease) in Stockholders' Equity                
Stock-based Compensation Expense   9,217           9,217
Treasury Stock Purchases for Restricted Stock Vests     $ (1,031)         (1,031)
Treasury Stock Purchases for Restricted Stock Vests (in shares)     20          
Issuance of Common Shares upon Stock Option and ESPP Exercise   5,738           5,738
Issuance of Common Shares upon Stock Option and ESPP Exercise (in shares) 136              
Issuance of Restricted Stock Awards   (967) $ 967          
Issuance of Restricted Stock Awards (in shares) 106   (16)          
Other comprehensive income/(loss)       (4,492)       (4,492)
Net (loss)/Income           6,094   6,094
Balance at Dec. 31, 2019 $ 1 200,800 $ (723) (4,871) $ (8) 17,584 $ (8) 212,791
Balance (in shares) at Dec. 31, 2019 12,105   15          
Increase (decrease) in Stockholders' Equity                
Stock-based Compensation Expense   12,936           12,936
Treasury Stock Purchases for Restricted Stock Vests     $ (1,523)         (1,523)
Treasury Stock Purchases for Restricted Stock Vests (in shares)     61          
Issuance of Common Shares upon Stock Option and ESPP Exercise   618           618
Issuance of Common Shares upon Stock Option and ESPP Exercise (in shares) 21              
Issuance of Restricted Stock Awards (in shares) 304              
Other comprehensive income/(loss)       (6,566)       (6,566)
Net (loss)/Income           (22,548)   (22,548)
Balance at Dec. 31, 2020 $ 1 214,354 $ (2,246) (11,437)   (4,972)   195,700
Balance (in shares) at Dec. 31, 2020 12,430   76          
Increase (decrease) in Stockholders' Equity                
Stock-based Compensation Expense   10,489           10,489
Treasury Stock Purchases for Restricted Stock Vests     $ (889)         (889)
Treasury Stock Purchases for Restricted Stock Vests (in shares)     28          
Issuance of Common Shares upon Stock Option and ESPP Exercise   2,069           2,069
Issuance of Common Shares upon Stock Option and ESPP Exercise (in shares) 56              
Dividends on Convertible Preferred Stock           (190)   (190)
Issuance of Restricted Stock Awards (in shares) 541              
Restricted Stock Awards Forfeitures   (1)           (1)
Restricted Stock Awards Forfeitures (in shares) (81)   (21)          
Other comprehensive income/(loss)       8,382       8,382
Issuance of Common Stock for Novitium Acquisition   91,199           91,199
Issuance of Common Stock for Novitium Acquisition (in shares) 2,467              
Issuance of Common Stock in Public Offering   69,734           69,734
Issuance of Common Stock in Public Offering (in shares) 1,500              
Issuance of Series A Convertible Preferred Stock from Mezzanine Equity               24,850
Net (loss)/Income           (42,603)   (42,603)
Balance at Dec. 31, 2021 $ 1 $ 387,844 $ (3,135) $ (3,055)   $ (47,765)   333,890
Balance (in shares) at Dec. 31, 2021 16,913   83          
Increase (decrease) in Stockholders' Equity                
Balance, permanent and temporary equity               $ 358,740